A prospective observational study of neurocognitive function and multimodal brain magnetic resonance imaging in patients with glycogen storage diseases
NCT ID NCT07908212
First seen Nov 02, 2026 · Last updated Nov 03, 2026 · Updated 1 time
Summary
The goal of this observational study is to learn about cognitive function and brain imaging findings in people with glycogen storage disease (GSD). The main questions it aims to answer are: * Do people with GSD perform differently on cognitive tests from people without GSD? * Do brain volume, brain structure, intracranial blood vessels, and blood flow differ between the two groups, and are these findings related to cognitive test results or measures of metabolic control? Researchers will compare people with GSD with healthy volunteers of similar age and sex. No treatment will be assigned as part of the study. Participants will: * Complete cognitive tests * Have a brain magnetic resonance imaging (MRI) scan using a 3-tesla scanner * Provide relevant medical history and clinical information
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 318 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
We enroll individuals diagnosed with glycogen storage disease who are able to complete cognitive assessments and brain MRI, and healthy volunteers matched for age and sex.
- Ages
-
3 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: GSD group: * Meeting the diagnostic criteria for GSD * Having relatively complete clinical data * Able to cooperate with cognitive assessments and neuroimaging examinations Control group: * Age within 5 years of GSD patients, matched for sex, and with similar educational level * No diagnosis of GSD * No chronic metabolic diseases such as hypertension, diabetes mellitus, or hyperlipidemia; no history of heavy smoking or alcohol drinking; and no history of hypoglycemia in childhood Exclusion Criteria: * Concurrent diagnosis of other neurological disorders * Presence of factors that may cause central nervous system (CNS) injury, such as premature birth or head trauma * Contraindications to magnetic resonance imaging * Inability of the patient or their family members to understand the conditions and objectives of this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glycogen storage disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Coordination of rare diseases at sanford
- Can a smarter glucose monitor stop dangerous lows? small study tests predictive alerts
- Robotic leg device shows promise for helping muscle disease patients walk
- Robotic exoskeleton shows promise for muscle disease patients
- New scan techniques aim to solve rare heart disease mysteries
- Scientists launch Largest-Ever study of Ultra-Rare GSDs